Clinical Trials Browser

INDUSTRY × Interventional × ocrelizumab × Clear all

NCT04189588 2023-10-06

versus

Phase 2 Completed

34 enrolled 11 charts

Oncology Patients Receiving Chemotherapy

NCT02723071 2016-03-30

A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)

Phase 1/2 Completed

Lymphoma, Non-Hodgkin